Patient Recruitment Applications & Studies

51. The Story Behind The Fastest-Recruiting COVID-19 Clinical Trial In Operation Warp Speed History 7/17/2023

    Learn how Citeline Connect supported the fastest-recruiting trial in the operation’s history, delivering 6,432 randomizations (22% of target), over 50% within the minority population, in a record-setting 48 days.

52. Supporting Utilization & Recruitment Through COVID-19 6/7/2023

    Supporting one of the world's largest pharmaceutical research organizations, MRN has more than doubled patient recruitment rates and quadrupled home visit referrals during the global outbreak of COVID-19.

53. Global Biotech Reduces Time To Randomize Target Population 5/26/2023

    Learn how a global biotech was able to overcome enrollment challenges during phase IIb orphan drug study by partnering with a solution provider.

54. Global Biotech Improves Clinical Trial Patient Recruitment With Digital Matching 5/26/2023

    A global biotech initiated a phase III study for severe allergic asthma. Study protocol originally accounted for enrolling 222 patients across nine UK-based investigator sites. After deploying traditional recruitment methods, the sponsor only managed to randomize 20% of the target patient population in 11 months. By partnering with a solution provider they were able to get patient recruitment back on track and meet enrollment targets faster, which would not have been possible with a traditional recruitment approach.

55. Global Travel Service Helps A Rare Disease Biotech Drive Retention 5/25/2023

    Discover how one global biotechnology company was able to receive seamless management of trial logistics and much-needed support for clinical trial participants.

56. A Nimble And Flexible Solution To Rescuing An Observational Study 5/8/2023

    Uncover how a European biotech was able to accelerate site start-up and exceed patient recruitment goals at more than 145 sites in North America, Europe, and Asia Pacific (APAC).

57. Retention Improved In A Pompe Disease Clinical Trial 4/18/2023

    Explore the ways one double-blind, randomized Phase 3 study was able to boost the participant’s overall adherence to the protocol and increase their willingness to continue with the trial.

58. Recruitment Improved With Home Trial Support 3/28/2023

    Discover how a complex oncology study with alternating visits between hospital, outpatient, and home was able to overcome enrollment issues.

59. NeuraLace Doubles Clinical Trial Enrollment & Improves Participant Compliance With EDC & ePRO 3/20/2023

    Find out how one company dedicated to producing innovative non-invasive chronic pain therapies was able to engage its patients in new ways.

60. Supporting Enrollment Of A Phase 2 Cervical Cancer Study During A Pandemic 10/13/2022

    The developer of an investigative medicinal product (IMP) for advanced, recurrent, non-resectable cervical cancer engaged Premier Research to assist with screening and enrollment in a Phase 2 study in Europe. Find out the results of this partnership.